NCT
HOME CURRENT ARCHIVE COVID-19
HOME CURRENT ARCHIVE PUBLISH INSTRUCTIONS
FOR AUTHORS COVID-19 LOG IN / REGISTER HISTORY ABOUT US DIRECTORY CONTACT
Obstructive pathologies of the airway: Asthma attack

Eduardo Contreras Zúñiga, Sandra Ximena Zuluaga Martínez, Isabel Cristina Casa Quiroga, Bibian Plaza Ramírez





2007, Number 4

2007; 66 (4)






ABSTRACT

Asthma is a chronic disease that is characterized by recurrent attacks of breathlessness and wheezing, which vary in severity and frequency from one person to another. Symptoms may come several times a day or week, and some people are aggravated during physical activity or in the evening. The recurring symptoms often cause insomnia, daytime fatigue, a decrease of the activity and truancy and labor. The fatality rate of asthma is relatively low compared with other chronic diseases, but in 2005 killed 255,000 people.

KEYWORDS

Bronchial asthma, bronchial hyper-reactivity, dyspnea.

REFERENCES

  1. Levi ML. International Primary Care Respiratory Group (IPCRG) Guidelines: diagnosis of respiratory diseases in primary care. Prim Care Respir J 2006; 15(1): 20-34.

  2. Siddiki AA. The incidence of adult asthma: a review. Int J Tuberc Lung Dis 2005; 9(6): 603-12.

  3. Castillo G. Crisis asmática. En: Guías de Atención Prehospitalaria. Ministerio de Protección Social. 2005.

  4. Asociación Colombiana de Neumología y Cirugía de Tórax. Comité Nacional Conjunto de Asma. ASMA. Guías para diagnóstico y manejo. Rev Colomb Neumol 2003; 15 (Supl 2): S1-S90.

  5. Apter J. Advances in adult asthma 2006: its risk factors, course, and management. J Allergy Clin Immunol 2007; 119(3): 563-6.

  6. Ellis K. Asthma pathogenesis and management. Nurse Pract 2006; 31(11): 24-37.

  7. Holgate ST. The mechanisms, diagnosis, and management of severe asthma in adults. Lancet 2006; 368(9537): 780-93.

  8. Larche M. Regulatory T cells in allergy and asthma. Chest 2007; 132(3): 1007-14.

  9. Finkelman F. Advances in asthma, allergy mechanisms, and genetics in 2006. J Allergy Clin Immunol 2007; 120(3): 544-50.

  10. Ducharme FM, Hicks GC. Anti-leukotriene agents compared to inhaled corticosteroids in the management of recurrent and/or chronic asthma in adults and children. In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.

  11. Pelaia G. Respiratory infections and asthma. Respir Med 2006; 100(5): 775-84.

  12. Morjaria JB. Anti-IgE in allergic asthma and rhinitis: an update. Expert Opin Biol Ther 2007; 7(11): 1739-47.

  13. Thomas M. Allergic rhinitis: evidence for impact on asthma. BMC Pulm Med 2006; 6 Suppl 1: S4.

  14. Mills T. The role of allergens in asthma. Am Fam Physician 2007; 76(5): 675-80.

  15. Palma AG. The asthma rhinitis link. Allerg Immunol (Paris) 2007; 39(6): 195-9.

  16. Von E. Asthma and allergies in rural areas of Europe. Proc Am Thorac Soc 2007; 4(3): 212-6.

  17. Grupo de Trabajo Respiratorio de la SAMFYC. Guía de Práctica Clínica de Asma. Sociedad Andaluza de Medicina Familiar y Comunitaria 26/2/2002.

  18. Tapps S. Education interventions for adults who attend the emergency room for acute asthma. Cochrane Database Syst Rev 2007; (3): CD003000.

  19. Irani AM. The challenge of mild persistent asthma. Ann Allergy Asthma Immunol 2005; 94(5): 517-27.

  20. National Institutes of Health (NIH). National Heart, Lung, and Blood Institute. Guidelines for the diagnosis and management of asthma. Expert Panel Report 2. NIH; 2004.

  21. Rodrigo GJ, Rodrigo C, Hall JB. Acute Asthma in adults: a review. Chest 2004; 125: 1081–1102.

  22. Rowe BH, Spooner C, Ducharme FM, Bretzlaff JA, Bota GW. Early emergency department treatment of acute asthma with systemic corticosteroids. In: The Cochrane Library, Issue 2, 2004 Chichester, UK: John Wiley & Sons, Ltd.

  23. Slaughter MC. Not quite asthma: differential diagnosis of dyspnea, cough, and wheezing. Allergy Asthma Proc 2007; 28(3): 271-81.

  24. Moore WC. Severe asthma: an overview. J Allergy Clin Immunol 2006; 117(3): 487-94.

  25. Apter AJ. Advances in adult and pediatric asthma. J Allergy Clin Immunol 2006; 117(3): 512-8.

  26. Scottish Intercollegiate Guidelines Network (SIGN). British guideline on the management of asthma. British Thoracic Society; 2004.

  27. Lopez A. Guidelines for the diagnosis and management of difficult-to-control asthma Arch Bronconeumol 2005; 41(9): 513-23.

  28. ICSI Health Care Guideline. Diagnosis and management of asthma. ICSI; 2003.

  29. Bush A. The challenge of asthma in adolescence. Pediatr Pulmonol 2007; 42(8): 683-92.

  30. Price D. Breaking new ground: challenging existing asthma guidelines. BMC Pulm Med 2006; 6 Suppl 1: S6.

  31. Holgate S. Asthma out of control? A structured review of recent patient surveys. BMC Pulm Med 2006; 6 Suppl 1: S2.

  32. Dennis R. Asthma. Clin Evid 2005; (14): 1847-77.

  33. Navarro RP. Asthma treatment guidelines: how do we measure up? Am J Manag Care 2005; 11(14 Suppl): S422-6.

  34. Rees J. Asthma control in adults. BMJ 2006; 332(7544): 767-71.

  35. Travers AH, Rowe BH, Barker S, et al. The effectiveness of IV b-Agonists in treating patients with acute asthma in the emergency department: A meta-analysis. Chest 2002; 122: 1200–1207.

  36. Shih Y. A cost-effectiveness analysis of first-line controller therapies for persistent asthma. Pharmacoeconomics 2007; 25(7): 577-90.

  37. Rodrigo GJ, Rodrigo C. Continuous vs intermittent b-agonists in the treatment of acute adult asthma: a systematic review with meta-analysis. Chest 2002; 122: 160–165.

  38. Cannon E. Aligning patient care and asthma treatment guidelines. Am J Manag Care 2005; 11(14 Suppl): S416-21.

  39. Corren J. Evaluation and treatment of asthma: an overview. Am J Manag Care 2005; 11(14 Suppl): S408-15.

  40. Becker A. Summary of recommendations from the Canadian Asthma Consensus guidelines, 2003. CMAJ 2005; 173(6 Suppl): S3-11.

  41. Emond S. Addition of intravenous aminophylline to b2-agonist in adults with acute asthma. Ann Emerg Med 2002; 40: 350–352.

  42. Rodrigo G, Rodrigo C, Burschtin O. Ipratropium bromide in acute adult severe asthma: a meta-analysis of randomized controlled trials. Am J Med 1999; 107: 363-370.

  43. Rodrigo GJ, Rodrigo C. The Role of Anticholinergics in acute asthma treatment: An evidence-based evaluation. Chest 2002; 121: 1977–1987.

  44. Restrepo R. Use of inhaled anticholinergic agents in obstructive airway disease. Respir Care 2007; 52(7): 833-51.

  45. Barnes PJ. Using a combination inhaler (budesonide plus formoterol) as rescue therapy improves asthma control. BMJ 2007; 335(7618): 513.

  46. Harrinson BD. Difficult asthma in adults: recognition and approaches to management. Intern Med J 2005; 35(9): 543-7.

  47. Weiss K. Clinical assessment of asthma symptom control: review of current assessment instruments. J Asthma 2006; 43(7): 481-7.

  48. Makino S. Pharmacologic control of asthma. Int Arch Allergy Immunol 2005; 136 Suppl 1: 14-49.

  49. Allayee H. The effect of montelukast and low-dose theophylline on cardiovascular disease risk factors in asthmatics. Chest 2007; 132(3): 868-74.

  50. Strom W. Update on montelukast and its role in the treatment of asthma, allergic rhinitis and exercise-induced bronchoconstriction. Expert Opin Pharmacother 2007; 8(13): 2173-87.

  51. Rowe BH, Spooner CH, Ducharme FM, Bretzlaff JA, Bota GW. Corticosteroids for preventing relapse following acute exacerbations of asthma. In: The Cochrane Library, Issue 2, 2004. Chichester, UK: John Wiley & Sons, Ltd.

  52. Blits M. Inhaled magnesium sulfate in the treatment of acute asthma. Cochrane Database Syst Rev 2005; (3): CD003898.

  53. Silverman RA, Osborn H, Bunge J, et al. IV magnesium sulfate in the treatment of acute severe asthma: a multicenter randomized controlled trial. Chest 2002; 122: 489–497.

  54. Bernard A. Management of an acute asthma attack. Aust Fam Physician 2005; 34(7): 531-4.

  55. Hondras MA. Manual therapy for asthma. Cochrane Database Syst Rev 2005; (2): CD001002.

  56. Rodrigo G. Heliox for nonintubated acute asthma patients. Cochrane Database Syst Rev 2006; (4): CD002884.

  57. Kim I. Heliox-driven albuterol nebulization for asthma exacerbations: an overview. Respir Care 2006; 51(6): 613.

  58. Brenan J. Noninvasive ventilation for critical care. Chest 2007; 132(2): 711-20.

  59. Ram FS. Non-invasive positive pressure ventilation for treatment of respiratory failure due to severe acute exacerbations of asthma. Cochrane Database Syst Rev 2005; (3): CD004360.

  60. Higgins BS. Permissive hypercapnia: role in protective lung ventilatory strategies. Curr Opin Crit Care 2005; 11(1): 56-62.

  61. Cook DH. Does noninvasive positive pressure ventilation improve outcome in acute hypoxemic respiratory failure? A systematic review. Crit Care Med 2004; 32(12): 2516-23.

  62. Tobias JD. Non-invasive ventilation using bilevel positive airway pressure to treat impending respiratory failure in the post anaesthesia care unit. J Clin Anesth 2000; 12: 409-12.

  63. Peigang Y, Marini JJ. Ventilation of patients with asthma and chronic obstructive pulmonary disease. Curr Opin Crit Care 2002; 8(1): 70-6.

  64. Rodrigo C. Severe acute asthma: its management in emergency visits and intensive care. Med Intensiva 2006; 30(9): 460-70.

  65. Pierson DJ. Indications for mechanical ventilation in adults with acute respiratory failure. Respir Care 2002; 47(3): 249-62.

  66. Mehta S, Hill NS. Noninvasive ventilation. Am J Respir Crit Care Med 2001; 163: 540-77.


2007, Number 4

2007; 66 (4)